Halozyme Therapeutic (HALO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 82,793 | 60,108 | 402,710 | 335,940 | 119,353 |
| Depreciation Amortization | 16,206 | 2,290 | 8,896 | 6,416 | 4,124 |
| Income taxes - deferred | -372 | 12,926 | -155,434 | -142,481 | N/A |
| Accounts receivable | -32,252 | -22,787 | 6,755 | -14,369 | -55,466 |
| Other Working Capital | -22,395 | -32,166 | 2,242 | -19,033 | -59,162 |
| Other Operating Activity | 44,042 | 27,426 | 34,271 | 50,451 | 86,336 |
| Operating Cash Flow | $88,022 | $47,797 | $299,440 | $216,924 | $95,185 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 500,306 | -48,815 | -404,832 | -105,521 | -89,063 |
| PPE Investments | 14,563 | -490 | -1,457 | -1,299 | -803 |
| Net Acquisitions | -999,120 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-484,251 | $-49,305 | $-406,289 | $-106,820 | $-89,866 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 370,000 | N/A | 784,875 | 784,875 | 784,875 |
| Debt Repayment | N/A | N/A | -369,064 | -369,064 | -369,064 |
| Common Stock Issued | 4,445 | 624 | 12,536 | 8,226 | 3,578 |
| Common Stock Repurchased | N/A | N/A | -350,058 | -189,737 | -125,021 |
| Other Financing Activity | -6,003 | 0 | -424 | -424 | -424 |
| Financing Cash Flow | $368,442 | $624 | $77,865 | $233,876 | $293,944 |
| Beginning Cash Position | 119,219 | 119,219 | 148,203 | 148,203 | 148,203 |
| End Cash Position | 91,432 | 118,335 | 119,219 | 492,183 | 447,466 |
| Net Cash Flow | $-27,787 | $-884 | $-28,984 | $343,980 | $299,263 |
| Free Cash Flow | |||||
| Operating Cash Flow | 88,022 | 47,797 | 299,440 | 216,924 | 95,185 |
| Capital Expenditure | -1,458 | -490 | -1,457 | -1,299 | -803 |
| Free Cash Flow | 86,564 | 47,307 | 297,983 | 215,625 | 94,382 |